EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis‐Independent Mechanism

Renfei Wu, Jingwei Li, Alexandra Aicher, Ke Jiang, Serena Tondi, Shuang Dong, Quan Zheng, Siqi Tang, Minchun Chen, Zhenyang Guo, Berina Šabanović, Preeta Ananthanarayanan und 6 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202308990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Renfei Wu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai, 200025, …. Hauptthemen laut MEDLINE: Pyroptosis, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Immune Evasion. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Education Commission, Natural Science Foundation China, ERC Advanced Investigator Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic and lethal disease. Gasdermins are primarily associated with necrosis via membrane permeabilization and pyroptosis, a lytic pro‐inflammatory type of cell death. In this study, GSDMC upregulation during PDAC progression is reported. GSDMC directly induces genes related to stemness, EMT, and immune evasion. Targeting Gsdmc in murine PDAC models reprograms the immunosuppressive tumor microenvironment, rescuing the recruitment of anti‐tumor immune cells through CXCL9. This not only results in diminished tumor initiation, growth and metastasis, but also enhances the response to KRAS G12D inhibition and PD‐1 checkpoint blockade, respectively. Mechanistically, it is discovered that ADAM17 cleaves GSDMC, releasing nuclear fragments binding to promoter regions of stemness, metastasis, and immune evasion‐related genes. Pharmacological inhibition of GSDMC cleavage or prevention of its nuclear translocation is equally effective in suppressing GSDMC's downstream targets and inhibiting PDAC progression. The findings establish GSDMC as a potential therapeutic target for enhancing treatment response in this deadly disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisPancreatic NeoplasmsCarcinoma, Pancreatic DuctalImmune EvasionAnimalsMiceHumansTumor MicroenvironmentDisease Models, AnimalCell Line, TumorNeoplastic Stem Cells

Stichwörter der Autor:innen

KRAS inhibitioncancer stem cellsgasdermin Cimmune evasionimmunotherapyinvasionmetastasispancreatic ductal adenocarcinoma

Autor:innen und Institutionen

  • Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai, 200025, P. R. China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai, 200025, P. R. China.
  • Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai, 200025, P. R. China.
  • Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiaotong University School of Medicine, 227 South Chongqing Road, Shanghai, 200025, P. R. C…
  • Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, No. 91, Xueshi Road, Taichung, 404, Taiwan.
  • Immunology Research and Development Center, China Medical University, No. 91, Xueshi Road, Taichung, 404, Taiwan.

ORCID-Profile: Christopher Heeschen

Förderung

  • Shanghai Municipal Education Commission
  • Natural Science Foundation China
  • ERC Advanced Investigator Grant
  • European Community's Seventh Framework Programme
  • Fondazione del Piemonte per l'Oncologia - IRCCS
  • Ministry of Science and Technology, Taiwan

Zitieren

APA

Wu, R., Li, J., Aicher, A., Jiang, K., Tondi, S., Dong, S., Zheng, Q., Tang, S., Chen, M., Guo, Z., Šabanović, B., Ananthanarayanan, P., Jiang, L., Sapino, A., Wen, C., Fu, D., Shen, B., & Heeschen, C. (2024). Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis‐Independent Mechanism. Advanced Science. https://doi.org/10.1002/advs.202308990

Vancouver

Wu R, Li J, Aicher A, Jiang K, Tondi S, Dong S, et al. Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis‐Independent Mechanism. Advanced Science. 2024. doi:10.1002/advs.202308990

BibTeX
@article{Wu2024,
  author = {Wu, Renfei and Li, Jingwei and Aicher, Alexandra and Jiang, Ke and Tondi, Serena and Dong, Shuang and Zheng, Quan and Tang, Siqi and Chen, Minchun and Guo, Zhenyang and Šabanović, Berina and Ananthanarayanan, Preeta and Jiang, Lingxi and Sapino, Anna and Wen, Chenlei and Fu, Da and Shen, Baiyong and Heeschen, Christopher},
  title = {Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis‐Independent Mechanism},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308990}
}
Kostenlos starten →